|
Real-time
Euronext Bruxelles
08:04:27 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 217.40 EUR | -0.23% |
|
+2.40% | -8.89% |
| 08-20 | Cancer vaccines finally garner the spotlight | ![]() |
| 08-19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
Chart: Technical Analysis
Stock exchange
Euronext Bruxelles
UCB 217.40 €
-0.23%
1.95M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Euronext Bruxelles
| UCB | 217.40EUR | -0.23% | 1.95M € | |
CBOE
| UCB | 217.40EUR | +0.51% | 503K € | |
OTC Markets
| UCBJF | 259.10USD | -0.86% | 29.28K $ | |
Xetra
| UNC | 212.50EUR | -0.93% | 10.62K € | |
London S.E.
| 0NZT | 216.15EUR | -1.19% | 1.08K € | |
Tradegate
| UNC | 218.40EUR | +0.28% | 218.4 € | |
Deutsche Boerse AG
| UNC | 218.00EUR | -0.46% | 0 € | |
CBOE
| 0NZT | 212.65EUR | 0.00% | 0 € | |
Wiener Boerse
| UCB | 217.70EUR | -0.41% | 0 € | |
Börse Stuttgart
| UNC | 218.40EUR | +0.37% | 0 € | |
Boerse Muenchen
| UNC | 218.10EUR | +0.23% | 0 € | |
Borsa Italiana
| 4UCB | 215.50EUR | +1.36% | 0 € | |
OTC Markets
| UCBJY | 126.10USD | -1.51% | 6.22M $ | |
Deutsche Boerse AG
| UNC0 | 109.00EUR | 0.00% | 0 € | |
Börse Stuttgart
| UNC0 | 106.00EUR | -1.85% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 229.2 | 247.6 | 279.5 |
| Spread/Res. | -5.15% | -12.20% | -22.22% |
| Spread/Supp. | +2.40% | +2.40% | +10.41% |
| Support | 212.3 | 212.3 | 196.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions


















